← Back to Search

ActionHealthNYC for Health Accessibility

N/A
Waitlist Available
Led By Rishi Sood, MPH
Research Sponsored by New York City Department of Health and Mental Hygiene
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
New York City residents who are uninsured, 19 and older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand whether the ActionHealthNYC program improves access to healthcare for low-income immigrants in NYC.

Who is the study for?
This trial is for uninsured New York City residents aged 19 or older who are not eligible for Medicaid, the Essential Plan, or private insurance through federal marketplace subsidies because of their immigration status. Participants must have incomes at or below 200% of the Federal Poverty Level.
What is being tested?
The study is testing the ActionHealthNYC program, which aims to improve healthcare access and coordination services for NYC immigrant residents without public insurance. It's a year-long demonstration to see if it helps participants get easier access to primary care and preventive services compared to non-participants.
What are the potential side effects?
Since this trial involves health service accessibility rather than medication or medical procedures, there aren't typical side effects associated with participation. However, any unexpected outcomes related to accessing healthcare services will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an uninsured adult living in New York City.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Improved access to healthcare
Secondary study objectives
Enhanced healthcare utilization
Enhanced utilization of preventive services
Reduced barriers to needed care

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MemberExperimental Treatment1 Intervention
The member group will be able to join ActionHealth NYC program, where they are assigned a primary care physician and have a standardized fee scale for services obtained in network. Laboratory, diagnostic, and specialty services can be obtained at network H+H locations. They will be offered recommended USPSTF A+B tests/screenings, HIV and TB screening (if indicated), and care coordination. If they are deemed "high risk," enhanced care coordination services will be offered.
Group II: StudyActive Control1 Intervention
The study group will be counseled on their options to access health care, including at public hospitals and community health centers. They will receive no additional services from the study.

Find a Location

Who is running the clinical trial?

New York City Department of Health and Mental HygieneLead Sponsor
18 Previous Clinical Trials
16,237 Total Patients Enrolled
New York City Human Resources AdministrationUNKNOWN
New York City Health and Hospitals CorporationOTHER
32 Previous Clinical Trials
6,045 Total Patients Enrolled
~258 spots leftby Nov 2025